Heart MRI Scans Can Enable More Accurate COVID-19 Diagnoses and Target Treatments More Effectively
|
By HospiMedica International staff writers Posted on 26 Feb 2021 |

Illustration
A new study has shown that some patients who have been discharged from hospital following severe COVID-19 illness have evidence of damage to their heart on MRI scans which can help identify different patterns of injury to enable more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.
In the study, researchers at Imperial College Healthcare (London, UK) studied 148 patients who had been hospitalized with severe COVID-19 and who showed raised levels of a protein called troponin in blood tests. Troponin is released into the blood when the heart is injured and can indicate possible damage. The patients studied had been very unwell, with one in three also having been on a ventilator in intensive care. They found that around half of these patients had evidence of damage to the heart on MRI scans performed, on average, around 10 weeks after discharge. Damage included inflammation of the heart muscle, scarring or death of heart tissue, restricted blood supply to the heart and combinations of all three.
Some patients who are hospitalized with COVID-19 have raised troponin levels during the most critical phase of their illness, which is when the body mounts an exaggerated immune response to the infection. Raised levels can occur when an artery becomes blocked or there is inflammation of the heart, but it can be challenging for clinicians to identify the extent or cause of the damage without imaging. The results also show that, despite being very unwell and having raised troponin levels, around half of the patients studied had no evidence on their scan of damage to their heart.
COVID-19 patients who had abnormal troponin levels had MRI scans of the heart after discharge as part of their normal care and these were compared with those from a control group of patients who had not had COVID-19, as well as with 40 healthy volunteers. The study found that around half of patients had evidence of injury, but also that different patterns occurred, suggesting that the heart may be at risk of different types of injury. The researchers also noted that in some cases MRI scans may be showing evidence of existing damage due to the patients’ underlying conditions. The researchers hope that the findings will provide insight into new ways of preventing injury to the heart in the first place, such as early treatment for blood clots, but also for identifying patients who would benefit from treatments to protect their heart function in the future.
“Raised troponin levels are associated with worse outcomes in COVID-19 patients and it is important to understand more about the extent and potential causes of heart damage,” said Dr. Graham Cole, consultant cardiologist at Imperial College Healthcare, who led the study. “MRI scans help identify different patterns of injury, which may enable us to make more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.”
Related Links:
Imperial College Healthcare
In the study, researchers at Imperial College Healthcare (London, UK) studied 148 patients who had been hospitalized with severe COVID-19 and who showed raised levels of a protein called troponin in blood tests. Troponin is released into the blood when the heart is injured and can indicate possible damage. The patients studied had been very unwell, with one in three also having been on a ventilator in intensive care. They found that around half of these patients had evidence of damage to the heart on MRI scans performed, on average, around 10 weeks after discharge. Damage included inflammation of the heart muscle, scarring or death of heart tissue, restricted blood supply to the heart and combinations of all three.
Some patients who are hospitalized with COVID-19 have raised troponin levels during the most critical phase of their illness, which is when the body mounts an exaggerated immune response to the infection. Raised levels can occur when an artery becomes blocked or there is inflammation of the heart, but it can be challenging for clinicians to identify the extent or cause of the damage without imaging. The results also show that, despite being very unwell and having raised troponin levels, around half of the patients studied had no evidence on their scan of damage to their heart.
COVID-19 patients who had abnormal troponin levels had MRI scans of the heart after discharge as part of their normal care and these were compared with those from a control group of patients who had not had COVID-19, as well as with 40 healthy volunteers. The study found that around half of patients had evidence of injury, but also that different patterns occurred, suggesting that the heart may be at risk of different types of injury. The researchers also noted that in some cases MRI scans may be showing evidence of existing damage due to the patients’ underlying conditions. The researchers hope that the findings will provide insight into new ways of preventing injury to the heart in the first place, such as early treatment for blood clots, but also for identifying patients who would benefit from treatments to protect their heart function in the future.
“Raised troponin levels are associated with worse outcomes in COVID-19 patients and it is important to understand more about the extent and potential causes of heart damage,” said Dr. Graham Cole, consultant cardiologist at Imperial College Healthcare, who led the study. “MRI scans help identify different patterns of injury, which may enable us to make more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.”
Related Links:
Imperial College Healthcare
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel








